Impact of CLK kinase inhibitors 1C8 and GPS167 on cancer cell proliferation and metastasis

FHS
May 21, 2024
3:52 am

A new research paper was published in Oncotarget’s Volume 15 on May 16, 2024, entitled, “The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response.”

CHOP study uncovers metabolic key to faster immune response

Researchers from Children’s Hospital of Philadelphia identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why

March 15, 2024

Gilead, Merck’s experimental long-acting HIV treatment heads to Phase 3

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 22, 2024

Breakthrough blood test improves early diagnosis of pancreatic cancer

An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests, reports a new study published in Cancer Letters.

October 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.